David Klatzmann

31.4k total citations · 9 hit papers
358 papers, 22.3k citations indexed

About

David Klatzmann is a scholar working on Immunology, Genetics and Molecular Biology. According to data from OpenAlex, David Klatzmann has authored 358 papers receiving a total of 22.3k indexed citations (citations by other indexed papers that have themselves been cited), including 194 papers in Immunology, 99 papers in Genetics and 69 papers in Molecular Biology. Recurrent topics in David Klatzmann's work include Immune Cell Function and Interaction (99 papers), T-cell and B-cell Immunology (99 papers) and Virus-based gene therapy research (81 papers). David Klatzmann is often cited by papers focused on Immune Cell Function and Interaction (99 papers), T-cell and B-cell Immunology (99 papers) and Virus-based gene therapy research (81 papers). David Klatzmann collaborates with scholars based in France, United States and United Kingdom. David Klatzmann's co-authors include Benoı̂t L. Salomon, Luc Montagnier, José L. Cohen, Michèlle Rosenzwajg, Denise Guétard, S. Chamaret, Jean‐Claude Gluckman, J Gruest, David Saadoun and P. Cacoub and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

David Klatzmann

349 papers receiving 21.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

1984 2.0k citations David Klatzmann et al. profile →
Natural regulatory T cells control the development of atherosclerosis in mice

2006 851 citations Benoı̂t L. Salomon, David Klatzmann et al. profile →
Isolation of a New Human Retrovirus from West African Patients with AIDS

1986 830 citations David Klatzmann et al. profile →
Selective Tropism of Lymphadenopathy Associated Virus (LAV) for Helper-Inducer T Lymphocytes

1984 807 citations David Klatzmann et al. profile →
CD4+CD25+ Immunoregulatory T Cells

2002 576 citations David Klatzmann, Benoı̂t L. Salomon et al. The Journal of Experimental Medicine profile →
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis

2011 554 citations David Saadoun, Michèlle Rosenzwajg et al. profile →
Nucleotide sequence of the visna lentivirus: relationship to the AIDS virus

1985 493 citations David Klatzmann et al. profile →
The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases

2015 459 citations David Klatzmann et al. profile →
Adaptation of Lymphadenopathy Associated Virus (LAV) to Replication in EBV-Transformed B Lymphoblastoid Cell Lines

1984 276 citations David Klatzmann et al. profile →

Peers

Countries citing papers authored by David Klatzmann

Since Specialization

Citations

This map shows the geographic impact of David Klatzmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Klatzmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Klatzmann more than expected).

Fields of papers citing papers by David Klatzmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Klatzmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Klatzmann. The network helps show where David Klatzmann may publish in the future.

Co-authorship network of co-authors of David Klatzmann

This figure shows the co-authorship network connecting the top 25 collaborators of David Klatzmann. A scholar is included among the top collaborators of David Klatzmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Klatzmann. David Klatzmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Serum intestinal permeability biomarkers are associated with erosive hand osteoarthritis and radiographic severity: results from the DIGICOD cohort 2025 ·Osteoarthritis and Cartilage ·(unknown), Soraya Fellahi, Jean‐Philippe Bastard, Alexandra Rousseau, Sophie Tuffet, Alice Courties, Audrey Pigenet, Kristell Wanherdrick, M. Kloppenburg, Pascal Richette, E. Maheu, M.D. Crema, David Klatzmann, Harry Sokol, Encarnita Mariotti‐Ferrandiz, Francis Bérenbaum, Jérémie Sellam	2
2	BLIMP-1 and CEACAM1 cooperatively regulate human Treg homeostasis and function to control xenogeneic GVHD 2025 ·JCI Insight ·Ying Ding, Aixin Yu, (unknown), Sabrina Copsel, (unknown), (unknown), (unknown), Nicolas Tchitchek, Michèlle Rosenzwajg, Alejandro V. Villarino, Robert B. Levy, David Klatzmann, Thomas R. Malek	0
3	Serum Intestinal Permeability Biomarkers are associated with erosive hand osteoarthritis and radiographic severity: Results: from the DIGICOD cohort 2024 ·Osteoarthritis and Cartilage ·(unknown), Soraya Fellahi, Jean‐Philippe Bastard, Alexandra Rousseau, Sophie Tuffet, Alice Courties, Audrey Pigenet, (unknown), M. Kloppenburg, Pascal Richette, E. Maheu, M.D. Crema, David Klatzmann, Harry Sokol, Encarnita Mariotti‐Ferrandiz, Francis Bérenbaum, Jérémie Sellam	1
4	Emerging Concepts and Success Stories in Type 1 Diabetes Research: A Road Map for a Bright Future 2024 ·Diabetes ·Roberto Mallone, Emily K. Sims, Peter Achenbach, Chantal Mathieu, Alberto Pugliese, Mark A. Atkinson, Sanjoy Dutta, Carmella Evans‐Molina, David Klatzmann, (unknown), S. Alice Long, L. Overbergh, Teresa Rodríguez-Calvo, Anette‐Gabriele Ziegler, Sylvaine You	3
5	Local and Global Variability in Developing Human T-Cell Repertoires 2024 ·PubMed ·(unknown), Valentin Quiniou, (unknown), (unknown), (unknown), (unknown), Encarnita Mariotti‐Ferrandiz, David Klatzmann, Aleksandra M. Walczak, Thierry Mora, Armita Nourmohammad	0
6	Reduction of Neutrophil Activation by Phosphodiesterase 4 Blockade in Behçet's Disease 2023 ·Arthritis & Rheumatology ·Alexandre Le Joncour, (unknown), (unknown), (unknown), Stéphane Barète, Pierre Fouret, Michèlle Rosenzwajg, David Klatzmann, P. Cacoub, David Saadoun	18
7	Human thymopoiesis produces polyspecific CD8+ α/β T cells responding to multiple viral antigens 2023 ·eLife ·Valentin Quiniou, (unknown), (unknown), (unknown), (unknown), Zhicheng Zhou, (unknown), Nicolas Coatnoan, (unknown), Hang‐Phuong Pham, Béatrice Clemenceau, Henri Vié, Mikhail Shugay, Adrien Six, (unknown), Roberto Mallone, Encarnita Mariotti‐Ferrandiz, David Klatzmann	8
8	Particulate antigens administrated by intranasal and intravaginal routes in a prime-boost strategy improve HIV-specific TFH generation, high-quality antibodies and long-lasting mucosal immunity 2023 ·European Journal of Pharmaceutics and Biopharmaceutics ·Thomas Vazquez, (unknown), Fabien Pitoiset, Béatrice Levacher, J. Vigneron, Luzia Mayr, (unknown), Benjamin Bonnet, Christiane Moog, David Klatzmann, Bertrand Bellier	2
9	Naive and memory CD4+ T cell subsets can contribute to the generation of human Tfh cells 2021 ·iScience ·(unknown), (unknown), (unknown), Nicolas Tchitchek, (unknown), (unknown), (unknown), Bruno Gouritin, Bénédicte Hoareau‐Coudert, Aurélien Corneau, Catherine Blanc, Éric Savier, Pierre Buffet, Adrien Six, David Klatzmann, Arnaud Moris, Stéphanie Graff‐Dubois	5
10	Anakinra reduces lung inflammation in experimental acute lung injury 2021 ·Immunity Inflammation and Disease ·Paul Engeroff, (unknown), Antoine Monsel, David Klatzmann	9
11	IL-2 antibodies in type 1 diabetes and during IL-2 therapy 2018 ·Diabetologia ·Guillaume Churlaud, Michèlle Rosenzwajg, P. Cacoub, David Saadoun, Dominique Valteau‐Couanet, Nathalie Chaput, Alberto Pugliese, David Klatzmann	4
12	High-resolution repertoire analysis reveals a major bystander activation of Tfh and Tfr cells 2018 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), (unknown), Valentin Quiniou, Wahiba Chaara, Karim El Soufi, Benjamin Bonnet, Adrien Six, Mikhail Shugay, Encarnita Mariotti‐Ferrandiz, David Klatzmann	49
13	Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells 2017 ·PLoS ONE ·Michel Lecendreux, Guillaume Churlaud, Fabien Pitoiset, Armelle Régnault, Tú-Anh Tran, Roland Liblau, David Klatzmann, Michèlle Rosenzwajg	38
14	Low-Dose IL-2 Induces Regulatory T Cell–Mediated Control of Experimental Food Allergy 2016 ·The Journal of Immunology ·Benjamin Bonnet, J. Vigneron, Béatrice Levacher, Thomas Vazquez, Fabien Pitoiset, (unknown), Guillaume Churlaud, David Klatzmann, Bertrand Bellier	43
15	Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation 2012 ·Arthritis Research & Therapy ·Benjamin Terrier, Nicolas Dérian, Y. Schoindre, Wahiba Chaara, Guillaume Géri, Noël Zahr, K. Mariampillai, Michèlle Rosenzwajg, Wassila Carpentier, Lucile Musset, Jean‐Charles Piette, Adrien Six, David Klatzmann, David Saadoun, P. Cacoub, N. Costedoat‐Chalumeau	147
16	IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells 2010 ·The Journal of Experimental Medicine ·Yenkel Grinberg‐Bleyer, Audrey Baeyens, Sylvaine You, Rima Elhage, Gwladys Fourcade, Sylvie Grégoire, Nicolas Cagnard, Wassila Carpentier, Qizhi Tang, Jeffrey A. Bluestone, Lucienne Chatenoud, David Klatzmann, Benoı̂t L. Salomon, Eliane Piaggio	338
17	Interleukin-25: a cytokine linking eosinophils and adaptive immunity in Churg-Strauss syndrome 2010 ·Blood ·Benjamin Terrier, Ivan Bièche, Thierry Maisonobe, Ingrid Laurendeau, Michèlle Rosenzwajg, Jean‐Emmanuel Kahn, Marie‐Claude Diemert, Lucile Musset, Michel Vidaud, D. Sène, N. Costedoat‐Chalumeau, (unknown), Zahir Amoura, David Klatzmann, P. Cacoub, David Saadoun	99
18	Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs 2010 ·Journal of Clinical Investigation ·Yenkel Grinberg‐Bleyer, David Saadoun, Audrey Baeyens, Fabienne Billiard, Jérémie D. Goldstein, Sylvie Grégoire, Gaëlle Martin, Rima Elhage, Nicolas Dérian, Wassila Carpentier, Gilles Marodon, David Klatzmann, Eliane Piaggio, Benoı̂t L. Salomon	138
19	Role of Regulatory T Cells in a New Mouse Model of Experimental Autoimmune Myositis 2009 ·American Journal Of Pathology ·Yves Allenbach, (unknown), Sylvie Grégoire, O. Dubourg, Benoı̂t L. Salomon, Gillian Butler‐Browne, Lucile Musset, S. Herson, David Klatzmann, Olivier Benvéniste	70
20	Transcriptional Targeting to Anterior Pituitary Lactotrophic Cells Using Recombinant Adenovirus Vectors in Vitro and in Vivo in Normal and Estrogen/Sulpiride-Induced Hyperplasic Anterior Pituitaries* 2000 ·Endocrinology ·T. D. Southgate, (unknown), Joseph R. Smith-Arica, Christian A. Gerdes, Marcelo J. Perone, Ian D. Morris, J.R. Davis, David Klatzmann, Pedro R. Löwenstein, María G. Castro	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact